| Literature DB >> 29494148 |
Fabio A Facchini1, Lenny Zaffaroni1, Alberto Minotti1, Silvia Rapisarda1, Valentina Calabrese1, Matilde Forcella1, Paola Fusi1, Cristina Airoldi1, Carlotta Ciaramelli1, Jean-Marc Billod2, Andra B Schromm3, Harald Braun4, Charys Palmer5, Rudi Beyaert4, Fabio Lapenta6, Roman Jerala6, Grisha Pirianov5, Sonsoles Martin-Santamaria2, Francesco Peri1.
Abstract
The structure-activity relationship was investigated in a series of synthetic TLR4 antagonists formed by a glucosamine core linked to two phosphate esters and two linear carbon chains. Molecular modeling showed that the compounds with 10, 12, and 14 carbons chains are associated with higher stabilization of the MD-2/TLR4 antagonist conformation than in the case of the C16 variant. Binding experiments with human MD-2 showed that the C12 and C14 variants have higher affinity than C10, while the C16 variant did not interact with the protein. The molecules, with the exception of the C16 variant, inhibited the LPS-stimulated TLR4 signal in human and murine cells, and the antagonist potency mirrored the MD-2 affinity calculated from in vitro binding experiments. Fourier-transform infrared, nuclear magnetic resonance, and small angle X-ray scattering measurements suggested that the aggregation state in aqueous solution depends on fatty acid chain lengths and that this property can influence TLR4 activity in this series of compounds.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29494148 DOI: 10.1021/acs.jmedchem.7b01803
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446